Tuberculous peritonitis.
Darrell G
DG
Finlay
Karen
K
Szauter
Gottumukkala S
GS
Raju
Ned
N
Snyder
D000328:Adult; D000911:Antibodies, Monoclonal / Q000009:adverse effects*; D018501:Antirheumatic Agents / Q000009:adverse effects* / Q000627:therapeutic use; D001172:Arthritis, Rheumatoid / Q000150:complications / Q000188:drug therapy; D001201:Ascites / Q000150:complications; D006801:Humans; D000069285:Infliximab; D008297:Male; D009169:Mycobacterium tuberculosis / Q000187:drug effects / Q000502:physiology; D014395:Peritonitis, Tuberculous / Q000139:chemically induced* / Q000382:microbiology; D012008:Recurrence; D013167:Spondylitis, Ankylosing / Q000150:complications / Q000188:drug therapy; D014409:Tumor Necrosis Factor-alpha / Q000037:antagonists & inhibitors
D000911:Antibodies, Monoclonal; D018501:Antirheumatic Agents; D014409:Tumor Necrosis Factor-alpha; D000069285:Infliximab